Top Bio Pharmaceutical Companies in USA
23 companies · $990.7 B combined market cap
Ranked by market cap
1–23 of 23
Ranked by market cap, ranked| # | Company | Country | Sector | Market cap↓ | Revenue↓ | Employees↓ | Since Jan 2024↓ |
|---|
| 73 | Amgen Inc.AMGN | 🇺🇸 USA | Healthcare | $249.2 B | $36.8 B | 25,200 | +53.6% |
| 104 | Gilead Sciences, Inc.GILD | 🇺🇸 USA | Healthcare | $193.5 B | $29.4 B | 17,000 | +83.9% |
| 171 | Vertex Pharmaceuticals IncorporatedVRTX | 🇺🇸 USA | Healthcare | $134.3 B | $12.0 B | 6,400 | +25.2% |
| 181 | Bristol-Myers Squibb CompanyBMY | 🇺🇸 USA | Healthcare | $125.5 B | $48.2 B | 32,500 | +17.9% |
| 275 | Moderna, Inc.MRNA | 🇺🇸 USA | Healthcare | $90.1 B | $1.9 B | 4,700 | +117.6% |
| 302 | Regeneron Pharmaceuticals, Inc.REGN | 🇺🇸 USA | Healthcare | $84.1 B | $14.3 B | 15,410 | -15.9% |
| 853 | Alnylam Pharmaceuticals, Inc.ALNY | 🇺🇸 USA | Healthcare | $30.1 B | $3.7 B | 2,500 | +24.6% |
| 1029 | Guardant Health, Inc.GH | 🇺🇸 USA | Healthcare | $24.1 B | $982 M | 2,506 | +681.3% |
| 1045 | Incyte CorporationINCY | 🇺🇸 USA | Healthcare | $23.8 B | $5.1 B | 2,844 | +59.5% |
| 1677 | Neurocrine Biosciences, Inc.NBIX | 🇺🇸 USA | Healthcare | $13.9 B | $2.9 B | 1,200 | +5.6% |
| 1980 | Bio-Techne CorporationTECH | 🇺🇸 USA | Healthcare | $11.4 B | $1.2 B | 3,000 | -0.6% |
| 2406 | Arrowhead Pharmaceuticals, Inc.ARWR | 🇺🇸 USA | Healthcare | $8.7 B | $451 M | 711 | +134.3% |
| 6328 | Agios Pharmaceuticals, Inc.AGIO | 🇺🇸 USA | Healthcare | $2.0 B | $54 M | 392 | +49.6% |
| — | Reata PharmaceuticalsRETAUnlisted | 🇺🇸 USA | Healthcare | $6.3 B (Jul 2023) | $2 M | 323 | — |
| — | Eidos Therapeutics6MX.MU | 🇺🇸 USA | Healthcare | $5.8 B (Jan 2021) | $27 M | 70 | — |
| — | Arena PharmaceuticalsARNAUnlisted | 🇺🇸 USA | Healthcare | $5.7 B (Jan 2022) | $0 M | 363 | — |
| — | Sage Therapeutics, Inc.SAGEUnlisted | 🇺🇸 USA | Healthcare | $1.3 B (Jan 2024) | $8 M | 471 | — |
| — | SpringWorks Therapeutics, Inc.SWTXUnlisted | 🇺🇸 USA | Healthcare | $2.8 B (Jan 2024) | $0 M | 176 | — |
| — | Allakos Inc.ALLKUnlisted | 🇺🇸 USA | Healthcare | $239 M (Jan 2024) | $0 M | 192 | — |
| — | NGM Biopharmaceuticals, Inc.NGMUnlisted | 🇺🇸 USA | Healthcare | $98 M (Jan 2024) | $77 M | 225 | — |
| — | G1 Therapeutics, Inc.GTHXUnlisted | 🇺🇸 USA | Healthcare | $161 M (Jan 2024) | $45 M | 148 | — |
| — | AthenexATNXUnlisted | 🇺🇸 USA | Healthcare | $24 M (Dec 2022) | $144 M | 605 | — |
| — | Medicines CompanyMDCOUnlisted | 🇺🇸 USA | Healthcare | $6.8 B (Jan 2020) | $1.2 B | — | — |